Background: Renal cell carcinoma (RCC) carries significant morbidity and mortality globally
with an increasing incidence per year predominantly represented by clear-cell renal cell …

Renal cell carcinoma (RCC) is the most common renal carcinoma in the human kidney. To
date, to the best of our knowledge, there are no biomarkers for the early monitoring and …

Objective This study aims to profile dysregulated microRNA (miRNA) expression in clear cell
renal cell carcinoma (ccRCC) and to identify key regulatory miRNAs in ccRCC. Methods and …

PURPOSE: Renal cell carcinoma is the most common neoplasm of the adult kidney.
Currently to our knowledge there are no biomarkers for diagnostic, prognostic or predictive …

Clear cell renal cell carcinoma (ccRCC), the most common subtype, accounts for
approximately 80% of all RCC cases. ccRCC patients typically present with an advanced …

The ever-increasing morbidity and mortality of clear cell renal cell carcinoma (ccRCC)
urgently demands updated biomarkers. MicroRNAs (miRNAs) are involved in diverse …

Accumulating evidence has demonstrated that some specific miRNAs were aberrantly
expressed in renal clear cell carcinoma and participated in many biological processes. The …

Background Renal cell carcinoma (RCC) stands as the most prevalent form of urogenital
cancer. However, there is currently no universally accepted method for predicting the …

Current studies suggest that some microRNAs (miRNAs) are associated with prognosis in
clear cell renal cell carcinoma (ccRCC). In this paper, we aimed to identify a miRNAs …

The lack of symptoms at the early stages of clear cell renal cell carcinoma (ccRCC) allows
the tumour to metastasize, leading to a dramatic reduction in patient survival. Therefore, we …